Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Aptiva Antiphospholipid Syndrome IgA Reagent
product1 mentionslast seen Sep 25, 2026
In vitro diagnostic reagent for semi-quantitative determination of anti-cardiolipin and anti-beta 2 glycoprotein 1 IgA antibodies.
Relationships 7
- U.S. Food and Drug AdministrationapprovesAptiva Antiphospholipid Syndrome IgA Reagent98% confidence1 source
- Aptiva Antiphospholipid Syndrome IgA Reagentdepends onparticle-based multi-analyte technology97% confidence1 source
- Aptiva Antiphospholipid Syndrome IgA Reagentconforms toCE Mark96% confidence1 source
- Aptiva Antiphospholipid Syndrome IgA Reagentconforms toFDA 510(k) clearance95% confidence1 source
- WerfendevelopsAptiva Antiphospholipid Syndrome IgA Reagent95% confidence1 source
- Aptiva Antiphospholipid Syndrome IgA Reagentcomposed ofparticle-based multi-analyte technology90% confidence1 source
- Aptiva Antiphospholipid Syndrome IgA Reagentapplies toantiphospholipid syndrome diagnosis85% confidence1 source
Relationship
U.S. Food and Drug AdministrationapprovesAptiva Antiphospholipid Syndrome IgA Reagent
98% confidence1 supporting mentionsfrom Sep 23, 2026
Either name opens that entity’s relationships.
Sources 1